尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Pitman Jama. Director active across 1 company, notably Deciphera Pharmaceuticals, Inc.. In total, 12 filings have been recorded. Breakdown: 0 buy · 5 sells. Total volume traded: €92k. History available since 15 December 2021. The latest transaction was filed on 15 February 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Pitman Jama is a declarant linked to Deciphera Pharmaceuticals, Inc. (XNAS), where the listed role is SVP, Chief Development Officer. He has 12 filings in total, and across the 12 sampled filings between 2021-12-17 and 2024-06-11, the reported transactions are sales for EUR 91559, with modal transaction nature listed as Attribution.